HomeCompareCKOCF vs JNJ

CKOCF vs JNJ: Dividend Comparison 2026

CKOCF yields 3.08% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CKOCF wins by $6.9K in total portfolio value
10 years
CKOCF
CKOCF
● Live price
3.08%
Share price
$27.11
Annual div
$0.83
5Y div CAGR
7.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.9K
Annual income
$856.48
Full CKOCF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CKOCF vs JNJ

📍 CKOCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCKOCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CKOCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CKOCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CKOCF
Annual income on $10K today (after 15% tax)
$261.59/yr
After 10yr DRIP, annual income (after tax)
$728.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CKOCF beats the other by $24.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CKOCF + JNJ for your $10,000?

CKOCF: 50%JNJ: 50%
100% JNJ50/50100% CKOCF
Portfolio after 10yr
$23.5K
Annual income
$842.13/yr
Blended yield
3.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CKOCF
No analyst data
Altman Z
4.6
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CKOCF buys
0
JNJ buys
0
No recent congressional trades found for CKOCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCKOCFJNJ
Forward yield3.08%3.36%
Annual dividend / share$0.83$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR7.7%5.8%
Portfolio after 10y$26.9K$20.0K
Annual income after 10y$856.48$827.78
Total dividends collected$5.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CKOCF vs JNJ ($10,000, DRIP)

YearCKOCF PortfolioCKOCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,031$331.45$10,676$355.77+$355.00CKOCF
2$12,172$368.03$11,407$389.39+$765.00CKOCF
3$13,432$408.73$12,198$426.53+$1.2KCKOCF
4$14,827$454.01$13,056$467.62+$1.8KCKOCF
5$16,369$504.42$13,987$513.12+$2.4KCKOCF
6$18,075$560.53$14,998$563.56+$3.1KCKOCF
7$19,964$623.01$16,098$619.52+$3.9KCKOCF
8$22,054$692.60$17,295$681.69+$4.8KCKOCF
9$24,368$770.12$18,599$750.82+$5.8KCKOCF
10$26,930$856.48$20,022$827.78+$6.9KCKOCF

CKOCF vs JNJ: Complete Analysis 2026

CKOCFStock

Chudenko Corporation operates as an equipment engineering company in Japan. It undertakes electrical works, such as light/outlet, image/sound/TV/broadcast, power receiving/transforming, and plant equipment works; energy-related works comprising wind/solar power generation, cogeneration, energy-saving power, and private power generation system works; and environment-related works, including recycling and heat storage system works. The company also undertakes electric line/distribution line/leading wire/underground line works; and office/household water and sewerage, and industrial water and sewerage facilities works, as well as constructs, maintains, and repairs roads and architecture. In addition, it is involved in the Internet/Intranet, CATV/community wireless system/telephone, LAN, optical and mobile communication, and OA floor equipment, as well as system integration and integrated information wiring works; air-conditioning/cooling, heating/water supply, drainage/sanitation/environment equipment, and clean room system works; and fire-alarm, theft monitoring/alarm, and firefighting/evacuation guidance equipment works. Further, the company engages in building equipment renewal and housing renovation works, as well as pylon works; designs, produces, sells, repairs, installs, and maintains electrical equipment, such as distribution boards, supervisory panels, control boards, power source equipment, communication devices, heavy current devices, various measuring devices, and others; and plans, develops, sells, rents, operates, and maintains software and information processing systems. Additionally, it provides consulting and maintenance services consisting of energy saving diagnosis/support services, as well as disaster prevention and firefighting equipment inspection services. The company was founded in 1944 and is headquartered in Hiroshima, Japan.

Full CKOCF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CKOCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CKOCF vs SCHDCKOCF vs JEPICKOCF vs OCKOCF vs KOCKOCF vs MAINCKOCF vs ABBVCKOCF vs MRKCKOCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.